These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22532561)

  • 21. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone.
    Liu B; Yang Y; Qiu Z; Staron M; Hong F; Li Y; Wu S; Li Y; Hao B; Bona R; Han D; Li Z
    Nat Commun; 2010 Sep; 1(6):79. PubMed ID: 20865800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α7 helix region of αI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis.
    Hong F; Liu B; Chiosis G; Gewirth DT; Li Z
    J Biol Chem; 2013 Jun; 288(25):18243-8. PubMed ID: 23671277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design.
    Verkhivker GM; Dixit A; Morra G; Colombo G
    Curr Top Med Chem; 2009; 9(15):1369-85. PubMed ID: 19860735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide.
    Triantafilou M; Triantafilou K
    Biochem Soc Trans; 2004 Aug; 32(Pt 4):636-9. PubMed ID: 15270695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors.
    Woodford MR; Dunn D; Miller JB; Jamal S; Neckers L; Mollapour M
    Adv Cancer Res; 2016; 129():31-50. PubMed ID: 26916000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
    Stravopodis DJ; Margaritis LH; Voutsinas GE
    Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
    Smith JR; Workman P
    Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding.
    Fearns C; Pan Q; Mathison JC; Chuang TH
    J Biol Chem; 2006 Nov; 281(45):34592-600. PubMed ID: 16968706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins.
    Ardi VC; Alexander LD; Johnson VA; McAlpine SR
    ACS Chem Biol; 2011 Dec; 6(12):1357-66. PubMed ID: 21950602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
    Li J; Soroka J; Buchner J
    Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.
    Wang J; Grishin AV; Ford HR
    J Immunol; 2016 Jun; 196(12):5130-7. PubMed ID: 27194788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages.
    Hsu HY; Wu HL; Tan SK; Li VP; Wang WT; Hsu J; Cheng CH
    Mol Pharmacol; 2007 Jan; 71(1):344-56. PubMed ID: 16868182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
    PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein 90 is an essential molecular chaperone for CB2 cannabinoid receptor-mediated signaling in trabecular meshwork cells.
    He F; Kumar A; Song ZH
    Mol Vis; 2012; 18():2839-46. PubMed ID: 23233786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp90 is required for transfer of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol.
    Taylor M; Navarro-Garcia F; Huerta J; Burress H; Massey S; Ireton K; Teter K
    J Biol Chem; 2010 Oct; 285(41):31261-7. PubMed ID: 20667832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
    Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
    J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.
    Garg G; Khandelwal A; Blagg BS
    Adv Cancer Res; 2016; 129():51-88. PubMed ID: 26916001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.
    Okada M; Itoh H; Hatakeyama T; Tokumitsu H; Kobayashi R
    Biochem J; 2003 Sep; 374(Pt 2):433-41. PubMed ID: 12803546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.